線維芽細胞成長因子受容体4の世界市場2020:メーカー別、地域別、種類・用途別

◆英語タイトル:Global Fibroblast Growth Factor Receptor 4 Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC05526
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月
◆ページ数:137
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥396,720見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥595,080見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥793,440見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalInfoResearch社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本書では、線維芽細胞成長因子受容体4の世界市場を調査対象にし、線維芽細胞成長因子受容体4の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(BLU-9931、BMS-986036、エルダフィチニブ、ES-135、FGF-401、その他)、用途別分析(乳がん、リンパ腫、黒色腫、卵管がん、肺がん、その他)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:Amgen Inc、Genosco Inc、Blueprint Medicines Corp、ArQule Inc、Eli Lilly and Co、AstraZeneca Plc、Incyte Corp、Eisai Co Ltd、Bristol-Myers Squibb Co、H3 Biomedicine Inc、Novartis AG、Vichem Chemie Research Ltd、Ionis Pharmaceuticals Inc、Principia Biopharma Inc、NGM Biopharmaceuticals Inc、Johnson & Johnson、Tasly Pharmaceutical Group Co Ltd、Merrimack Pharmaceuticals Inc
・メーカー別販売量、売上、市場シェア
・線維芽細胞成長因子受容体4の地域別市場分析
・線維芽細胞成長因子受容体4の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・線維芽細胞成長因子受容体4のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・線維芽細胞成長因子受容体4のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・線維芽細胞成長因子受容体4の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・線維芽細胞成長因子受容体4の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・線維芽細胞成長因子受容体4の種類別市場規模2015-2020:BLU-9931、BMS-986036、エルダフィチニブ、ES-135、FGF-401、その他
・線維芽細胞成長因子受容体4の用途別市場規模2015-2020:乳がん、リンパ腫、黒色腫、卵管がん、肺がん、その他
・線維芽細胞成長因子受容体4の世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論
【レポートの概要】

Market Overview
The global Fibroblast Growth Factor Receptor 4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Fibroblast Growth Factor Receptor 4 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Fibroblast Growth Factor Receptor 4 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Fibroblast Growth Factor Receptor 4 market has been segmented into
BLU-9931
BMS-986036
Erdafitinib
ES-135
FGF-401
Others

By Application, Fibroblast Growth Factor Receptor 4 has been segmented into:
Breast Cancer
Lymphoma
Melanoma
Fallopian Tube Cancer
Lung Cancer
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Fibroblast Growth Factor Receptor 4 market presented in the report. This section sheds light on the sales growth of different regional and country-level Fibroblast Growth Factor Receptor 4 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Fibroblast Growth Factor Receptor 4 market.

The report offers in-depth assessment of the growth and other aspects of the Fibroblast Growth Factor Receptor 4 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Fibroblast Growth Factor Receptor 4 Market Share Analysis
Fibroblast Growth Factor Receptor 4 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Fibroblast Growth Factor Receptor 4 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Fibroblast Growth Factor Receptor 4 sales, revenue and market share for each player covered in this report.

The major players covered in Fibroblast Growth Factor Receptor 4 are:
Amgen Inc
Genosco Inc
Blueprint Medicines Corp
ArQule Inc
Eli Lilly and Co
AstraZeneca Plc
Incyte Corp
Eisai Co Ltd
Bristol-Myers Squibb Co
H3 Biomedicine Inc
Novartis AG
Vichem Chemie Research Ltd
Ionis Pharmaceuticals Inc
Principia Biopharma Inc
NGM Biopharmaceuticals Inc
Johnson & Johnson
Tasly Pharmaceutical Group Co Ltd
Merrimack Pharmaceuticals Inc

Among other players domestic and global, Fibroblast Growth Factor Receptor 4 market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fibroblast Growth Factor Receptor 4 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Fibroblast Growth Factor Receptor 4, with price, sales, revenue and global market share of Fibroblast Growth Factor Receptor 4 in 2018 and 2019.
Chapter 3, the Fibroblast Growth Factor Receptor 4 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fibroblast Growth Factor Receptor 4 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Fibroblast Growth Factor Receptor 4 market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Fibroblast Growth Factor Receptor 4 sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Fibroblast Growth Factor Receptor 4 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fibroblast Growth Factor Receptor 4 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 BLU-9931
1.2.3 BMS-986036
1.2.4 Erdafitinib
1.2.5 ES-135
1.2.6 FGF-401
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Fibroblast Growth Factor Receptor 4 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.3.4 Melanoma
1.3.5 Fallopian Tube Cancer
1.3.6 Lung Cancer
1.3.7 Others
1.4 Overview of Global Fibroblast Growth Factor Receptor 4 Market
1.4.1 Global Fibroblast Growth Factor Receptor 4 Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen Inc
2.1.1 Amgen Inc Details
2.1.2 Amgen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen Inc SWOT Analysis
2.1.4 Amgen Inc Product and Services
2.1.5 Amgen Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Genosco Inc
2.2.1 Genosco Inc Details
2.2.2 Genosco Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Genosco Inc SWOT Analysis
2.2.4 Genosco Inc Product and Services
2.2.5 Genosco Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Blueprint Medicines Corp
2.3.1 Blueprint Medicines Corp Details
2.3.2 Blueprint Medicines Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Blueprint Medicines Corp SWOT Analysis
2.3.4 Blueprint Medicines Corp Product and Services
2.3.5 Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 ArQule Inc
2.4.1 ArQule Inc Details
2.4.2 ArQule Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 ArQule Inc SWOT Analysis
2.4.4 ArQule Inc Product and Services
2.4.5 ArQule Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly and Co
2.5.1 Eli Lilly and Co Details
2.5.2 Eli Lilly and Co Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly and Co SWOT Analysis
2.5.4 Eli Lilly and Co Product and Services
2.5.5 Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca Plc
2.6.1 AstraZeneca Plc Details
2.6.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AstraZeneca Plc SWOT Analysis
2.6.4 AstraZeneca Plc Product and Services
2.6.5 AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Incyte Corp
2.7.1 Incyte Corp Details
2.7.2 Incyte Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Incyte Corp SWOT Analysis
2.7.4 Incyte Corp Product and Services
2.7.5 Incyte Corp Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eisai Co Ltd
2.8.1 Eisai Co Ltd Details
2.8.2 Eisai Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eisai Co Ltd SWOT Analysis
2.8.4 Eisai Co Ltd Product and Services
2.8.5 Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bristol-Myers Squibb Co
2.9.1 Bristol-Myers Squibb Co Details
2.9.2 Bristol-Myers Squibb Co Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bristol-Myers Squibb Co SWOT Analysis
2.9.4 Bristol-Myers Squibb Co Product and Services
2.9.5 Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 H3 Biomedicine Inc
2.10.1 H3 Biomedicine Inc Details
2.10.2 H3 Biomedicine Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 H3 Biomedicine Inc SWOT Analysis
2.10.4 H3 Biomedicine Inc Product and Services
2.10.5 H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Novartis AG
2.11.1 Novartis AG Details
2.11.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Novartis AG SWOT Analysis
2.11.4 Novartis AG Product and Services
2.11.5 Novartis AG Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Vichem Chemie Research Ltd
2.12.1 Vichem Chemie Research Ltd Details
2.12.2 Vichem Chemie Research Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Vichem Chemie Research Ltd SWOT Analysis
2.12.4 Vichem Chemie Research Ltd Product and Services
2.12.5 Vichem Chemie Research Ltd Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ionis Pharmaceuticals Inc
2.13.1 Ionis Pharmaceuticals Inc Details
2.13.2 Ionis Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ionis Pharmaceuticals Inc SWOT Analysis
2.13.4 Ionis Pharmaceuticals Inc Product and Services
2.13.5 Ionis Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Principia Biopharma Inc
2.14.1 Principia Biopharma Inc Details
2.14.2 Principia Biopharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Principia Biopharma Inc SWOT Analysis
2.14.4 Principia Biopharma Inc Product and Services
2.14.5 Principia Biopharma Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 NGM Biopharmaceuticals Inc
2.15.1 NGM Biopharmaceuticals Inc Details
2.15.2 NGM Biopharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 NGM Biopharmaceuticals Inc SWOT Analysis
2.15.4 NGM Biopharmaceuticals Inc Product and Services
2.15.5 NGM Biopharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Johnson & Johnson
2.16.1 Johnson & Johnson Details
2.16.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Johnson & Johnson SWOT Analysis
2.16.4 Johnson & Johnson Product and Services
2.16.5 Johnson & Johnson Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Tasly Pharmaceutical Group Co Ltd
2.17.1 Tasly Pharmaceutical Group Co Ltd Details
2.17.2 Tasly Pharmaceutical Group Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Tasly Pharmaceutical Group Co Ltd SWOT Analysis
2.17.4 Tasly Pharmaceutical Group Co Ltd Product and Services
2.17.5 Tasly Pharmaceutical Group Co Ltd Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Merrimack Pharmaceuticals Inc
2.18.1 Merrimack Pharmaceuticals Inc Details
2.18.2 Merrimack Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Merrimack Pharmaceuticals Inc SWOT Analysis
2.18.4 Merrimack Pharmaceuticals Inc Product and Services
2.18.5 Merrimack Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Fibroblast Growth Factor Receptor 4 Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Fibroblast Growth Factor Receptor 4 Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Fibroblast Growth Factor Receptor 4 Manufacturer Market Share in 2019
3.3.2 Top 6 Fibroblast Growth Factor Receptor 4 Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Fibroblast Growth Factor Receptor 4 Sales, Revenue and Market Share by Regions
4.1.1 Global Fibroblast Growth Factor Receptor 4 Sales and Market Share by Regions (2015-2020)
4.1.2 Global Fibroblast Growth Factor Receptor 4 Revenue and Market Share by Regions (2015-2020)
4.2 North America Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
4.3 Europe Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
4.5 South America Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Fibroblast Growth Factor Receptor 4 Sales, Revenue and Market Share by Country
5.1.1 North America Fibroblast Growth Factor Receptor 4 Sales and Market Share by Country (2015-2020)
5.1.2 North America Fibroblast Growth Factor Receptor 4 Revenue and Market Share by Country (2015-2020)
5.2 United States Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
5.3 Canada Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
5.4 Mexico Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Fibroblast Growth Factor Receptor 4 Sales, Revenue and Market Share by Country
6.1.1 Europe Fibroblast Growth Factor Receptor 4 Sales and Market Share by Country (2015-2020)
6.1.2 Europe Fibroblast Growth Factor Receptor 4 Revenue and Market Share by Country (2015-2020)
6.2 Germany Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
6.3 UK Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
6.4 France Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
6.5 Russia Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
6.6 Italy Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Fibroblast Growth Factor Receptor 4 Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Fibroblast Growth Factor Receptor 4 Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Fibroblast Growth Factor Receptor 4 Revenue and Market Share by Regions (2015-2020)
7.2 China Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
7.3 Japan Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
7.4 Korea Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
7.5 India Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
7.7 Australia Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Fibroblast Growth Factor Receptor 4 Sales, Revenue and Market Share by Country
8.1.1 South America Fibroblast Growth Factor Receptor 4 Sales and Market Share by Country (2015-2020)
8.1.2 South America Fibroblast Growth Factor Receptor 4 Revenue and Market Share by Country (2015-2020)
8.2 Brazil Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
8.3 Argentina Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Fibroblast Growth Factor Receptor 4 Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Fibroblast Growth Factor Receptor 4 Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Fibroblast Growth Factor Receptor 4 Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
9.3 Turkey Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
9.4 Egypt Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
9.5 South Africa Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Fibroblast Growth Factor Receptor 4 Sales and Market Share by Type (2015-2020)
10.2 Global Fibroblast Growth Factor Receptor 4 Revenue and Market Share by Type (2015-2020)
10.3 Global Fibroblast Growth Factor Receptor 4 Price by Type (2015-2020)
11 Global Fibroblast Growth Factor Receptor 4 Market Segment by Application
11.1 Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Application (2015-2020)
11.2 Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Application (2015-2020)
11.3 Global Fibroblast Growth Factor Receptor 4 Price by Application (2015-2020)
12 Market Forecast
12.1 Global Fibroblast Growth Factor Receptor 4 Sales, Revenue and Growth Rate (2021-2025)
12.2 Fibroblast Growth Factor Receptor 4 Market Forecast by Regions (2021-2025)
12.2.1 North America Fibroblast Growth Factor Receptor 4 Market Forecast (2021-2025)
12.2.2 Europe Fibroblast Growth Factor Receptor 4 Market Forecast (2021-2025)
12.2.3 Asia-Pacific Fibroblast Growth Factor Receptor 4 Market Forecast (2021-2025)
12.2.4 South America Fibroblast Growth Factor Receptor 4 Market Forecast (2021-2025)
12.2.5 Middle East & Africa Fibroblast Growth Factor Receptor 4 Market Forecast (2021-2025)
12.3 Fibroblast Growth Factor Receptor 4 Market Forecast by Type (2021-2025)
12.3.1 Global Fibroblast Growth Factor Receptor 4 Sales Forecast by Type (2021-2025)
12.3.2 Global Fibroblast Growth Factor Receptor 4 Market Share Forecast by Type (2021-2025)
12.4 Fibroblast Growth Factor Receptor 4 Market Forecast by Application (2021-2025)
12.4.1 Global Fibroblast Growth Factor Receptor 4 Sales Forecast by Application (2021-2025)
12.4.2 Global Fibroblast Growth Factor Receptor 4 Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Fibroblast Growth Factor Receptor 4 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Fibroblast Growth Factor Receptor 4 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Fibroblast Growth Factor Receptor 4 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Inc Fibroblast Growth Factor Receptor 4 Major Business
Table 9. Amgen Inc Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 10. Amgen Inc SWOT Analysis
Table 11. Amgen Inc Fibroblast Growth Factor Receptor 4 Product and Services
Table 12. Amgen Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Genosco Inc Basic Information, Manufacturing Base and Competitors
Table 14. Genosco Inc Fibroblast Growth Factor Receptor 4 Major Business
Table 15. Genosco Inc Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 16. Genosco Inc SWOT Analysis
Table 17. Genosco Inc Fibroblast Growth Factor Receptor 4 Product and Services
Table 18. Genosco Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Blueprint Medicines Corp Basic Information, Manufacturing Base and Competitors
Table 20. Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Major Business
Table 21. Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 22. Blueprint Medicines Corp SWOT Analysis
Table 23. Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Product and Services
Table 24. Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. ArQule Inc Basic Information, Manufacturing Base and Competitors
Table 26. ArQule Inc Fibroblast Growth Factor Receptor 4 Major Business
Table 27. ArQule Inc Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 28. ArQule Inc SWOT Analysis
Table 29. ArQule Inc Fibroblast Growth Factor Receptor 4 Product and Services
Table 30. ArQule Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Eli Lilly and Co Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Major Business
Table 33. Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 34. Eli Lilly and Co SWOT Analysis
Table 35. Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Product and Services
Table 36. Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 38. AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Major Business
Table 39. AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 40. AstraZeneca Plc SWOT Analysis
Table 41. AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Product and Services
Table 42. AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Incyte Corp Basic Information, Manufacturing Base and Competitors
Table 44. Incyte Corp Fibroblast Growth Factor Receptor 4 Major Business
Table 45. Incyte Corp Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 46. Incyte Corp SWOT Analysis
Table 47. Incyte Corp Fibroblast Growth Factor Receptor 4 Product and Services
Table 48. Incyte Corp Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Eisai Co Ltd Basic Information, Manufacturing Base and Competitors
Table 50. Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Major Business
Table 51. Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 52. Eisai Co Ltd SWOT Analysis
Table 53. Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Product and Services
Table 54. Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table 56. Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Major Business
Table 57. Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 58. Bristol-Myers Squibb Co SWOT Analysis
Table 59. Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Product and Services
Table 60. Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. H3 Biomedicine Inc Basic Information, Manufacturing Base and Competitors
Table 62. H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Major Business
Table 63. H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 64. H3 Biomedicine Inc SWOT Analysis
Table 65. H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Product and Services
Table 66. H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 68. Novartis AG Fibroblast Growth Factor Receptor 4 Major Business
Table 69. Novartis AG Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 70. Novartis AG SWOT Analysis
Table 71. Novartis AG Fibroblast Growth Factor Receptor 4 Product and Services
Table 72. Novartis AG Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Vichem Chemie Research Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Vichem Chemie Research Ltd Fibroblast Growth Factor Receptor 4 Major Business
Table 75. Vichem Chemie Research Ltd Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 76. Vichem Chemie Research Ltd SWOT Analysis
Table 77. Vichem Chemie Research Ltd Fibroblast Growth Factor Receptor 4 Product and Services
Table 78. Vichem Chemie Research Ltd Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Ionis Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 80. Ionis Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Major Business
Table 81. Ionis Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 82. Ionis Pharmaceuticals Inc SWOT Analysis
Table 83. Ionis Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Product and Services
Table 84. Ionis Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Principia Biopharma Inc Basic Information, Manufacturing Base and Competitors
Table 86. Principia Biopharma Inc Fibroblast Growth Factor Receptor 4 Major Business
Table 87. Principia Biopharma Inc Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 88. Principia Biopharma Inc SWOT Analysis
Table 89. Principia Biopharma Inc Fibroblast Growth Factor Receptor 4 Product and Services
Table 90. Principia Biopharma Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. NGM Biopharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 92. NGM Biopharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Major Business
Table 93. NGM Biopharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 94. NGM Biopharmaceuticals Inc SWOT Analysis
Table 95. NGM Biopharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Product and Services
Table 96. NGM Biopharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 98. Johnson & Johnson Fibroblast Growth Factor Receptor 4 Major Business
Table 99. Johnson & Johnson Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 100. Johnson & Johnson SWOT Analysis
Table 101. Johnson & Johnson Fibroblast Growth Factor Receptor 4 Product and Services
Table 102. Johnson & Johnson Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Tasly Pharmaceutical Group Co Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Tasly Pharmaceutical Group Co Ltd Fibroblast Growth Factor Receptor 4 Major Business
Table 105. Tasly Pharmaceutical Group Co Ltd Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 106. Tasly Pharmaceutical Group Co Ltd SWOT Analysis
Table 107. Tasly Pharmaceutical Group Co Ltd Fibroblast Growth Factor Receptor 4 Product and Services
Table 108. Tasly Pharmaceutical Group Co Ltd Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Merrimack Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Type and Application
Table 110. Merrimack Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Major Business
Table 111. Merrimack Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 112. Merrimack Pharmaceuticals Inc SWOT Analysis
Table 113. Merrimack Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Product and Services
Table 114. Merrimack Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Global Fibroblast Growth Factor Receptor 4 Sales by Manufacturer (2018-2019) (K Pcs)
Table 116. Global Fibroblast Growth Factor Receptor 4 Revenue by Manufacturer (2018-2019) (USD Million)
Table 117. Global Fibroblast Growth Factor Receptor 4 Sales by Regions (2015-2020) (K Pcs)
Table 118. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Regions (2015-2020)
Table 119. Global Fibroblast Growth Factor Receptor 4 Revenue by Regions (2015-2020) (USD Million)
Table 120. North America Fibroblast Growth Factor Receptor 4 Sales by Countries (2015-2020) (K Pcs)
Table 121. North America Fibroblast Growth Factor Receptor 4 Sales Market Share by Countries (2015-2020)
Table 122. North America Fibroblast Growth Factor Receptor 4 Revenue by Countries (2015-2020) (USD Million)
Table 123. North America Fibroblast Growth Factor Receptor 4 Revenue Market Share by Countries (2015-2020)
Table 124. Europe Fibroblast Growth Factor Receptor 4 Sales by Countries (2015-2020) (K Pcs)
Table 125. Europe Fibroblast Growth Factor Receptor 4 Sales Market Share by Countries (2015-2020)
Table 126. Europe Fibroblast Growth Factor Receptor 4 Revenue by Countries (2015-2020) (USD Million)
Table 127. Asia-Pacific Fibroblast Growth Factor Receptor 4 Sales by Regions (2015-2020) (K Pcs)
Table 128. Asia-Pacific Fibroblast Growth Factor Receptor 4 Sales Market Share by Regions (2015-2020)
Table 129. Asia-Pacific Fibroblast Growth Factor Receptor 4 Revenue by Regions (2015-2020) (USD Million)
Table 130. South America Fibroblast Growth Factor Receptor 4 Sales by Countries (2015-2020) (K Pcs)
Table 131. South America Fibroblast Growth Factor Receptor 4 Sales Market Share by Countries (2015-2020)
Table 132. South America Fibroblast Growth Factor Receptor 4 Revenue by Countries (2015-2020) (USD Million)
Table 133. South America Fibroblast Growth Factor Receptor 4 Revenue Market Share by Countries (2015-2020)
Table 134. Middle East & Africa Fibroblast Growth Factor Receptor 4 Sales by Countries (2015-2020) (K Pcs)
Table 135. Middle East & Africa Fibroblast Growth Factor Receptor 4 Sales Market Share by Countries (2015-2020)
Table 136. Middle East & Africa Fibroblast Growth Factor Receptor 4 Revenue by Countries (2015-2020) (USD Million)
Table 137. Middle East & Africa Fibroblast Growth Factor Receptor 4 Revenue Market Share by Countries (2015-2020)
Table 138. Global Fibroblast Growth Factor Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 139. Global Fibroblast Growth Factor Receptor 4 Sales Share by Type (2015-2020)
Table 140. Global Fibroblast Growth Factor Receptor 4 Revenue by Type (2015-2020) (USD Million)
Table 141. Global Fibroblast Growth Factor Receptor 4 Revenue Share by Type (2015-2020)
Table 142. Global Fibroblast Growth Factor Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 143. Global Fibroblast Growth Factor Receptor 4 Sales Share by Application (2015-2020)
Table 144. Global Fibroblast Growth Factor Receptor 4 Sales Forecast by Regions (2021-2025) (K Pcs)
Table 145. Global Fibroblast Growth Factor Receptor 4 Market Share Forecast by Regions (2021-2025)
Table 146. Global Fibroblast Growth Factor Receptor 4 Sales Forecast by Type (2021-2025) (K Pcs)
Table 147. Global Fibroblast Growth Factor Receptor 4 Market Share Forecast by Type (2021-2025)
Table 148. Global Fibroblast Growth Factor Receptor 4 Sales Forecast by Application (2021-2025)
Table 149. Global Fibroblast Growth Factor Receptor 4 Market Share Forecast by Application (2021-2025)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Fibroblast Growth Factor Receptor 4 Picture
Figure 2. Global Sales Market Share of Fibroblast Growth Factor Receptor 4 by Type in 2019
Figure 3. BLU-9931 Picture
Figure 4. BMS-986036 Picture
Figure 5. Erdafitinib Picture
Figure 6. ES-135 Picture
Figure 7. FGF-401 Picture
Figure 8. Others Picture
Figure 9. Fibroblast Growth Factor Receptor 4 Sales Market Share by Application in 2018
Figure 10. Breast Cancer Picture
Figure 11. Lymphoma Picture
Figure 12. Melanoma Picture
Figure 13. Fallopian Tube Cancer Picture
Figure 14. Lung Cancer Picture
Figure 15. Others Picture
Figure 16. Global Fibroblast Growth Factor Receptor 4 Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey Fibroblast Growth Factor Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Manufacturer in 2019
Figure 37. Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 Fibroblast Growth Factor Receptor 4 Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 Fibroblast Growth Factor Receptor 4 Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 42. Global Fibroblast Growth Factor Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Regions (2015-2020)
Figure 44. Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Regions in 2018
Figure 45. North America Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
Figure 46. Europe Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
Figure 48. South America Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020)
Figure 50. North America Fibroblast Growth Factor Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America Fibroblast Growth Factor Receptor 4 Sales Market Share by Countries (2015-2020)
Figure 52. North America Fibroblast Growth Factor Receptor 4 Sales Market Share by Countries in 2018
Figure 53. North America Fibroblast Growth Factor Receptor 4 Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America Fibroblast Growth Factor Receptor 4 Revenue Market Share by Countries in 2018
Figure 55. United States Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Canada Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Mexico Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Europe Fibroblast Growth Factor Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe Fibroblast Growth Factor Receptor 4 Revenue Market Share by Countries (2015-2020)
Figure 60. Europe Fibroblast Growth Factor Receptor 4 Revenue Market Share by Countries in 2019
Figure 61. Germany Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. UK Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. France Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Russia Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Italy Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Asia-Pacific Fibroblast Growth Factor Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific Fibroblast Growth Factor Receptor 4 Sales Market Share by Regions 2019
Figure 68. Asia-Pacific Fibroblast Growth Factor Receptor 4 Revenue Market Share by Regions 2019
Figure 69. China Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Korea Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. India Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Southeast Asia Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. South America Fibroblast Growth Factor Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America Fibroblast Growth Factor Receptor 4 Sales Market Share by Countries in 2019
Figure 76. South America Fibroblast Growth Factor Receptor 4 Revenue Market Share by Countries in 2019
Figure 77. Brazil Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Argentina Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Middle East and Africa Fibroblast Growth Factor Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa Fibroblast Growth Factor Receptor 4 Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa Fibroblast Growth Factor Receptor 4 Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa Fibroblast Growth Factor Receptor 4 Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Egypt Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Turkey Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. South Africa Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 87. Global Fibroblast Growth Factor Receptor 4 Sales and Growth Rate (2021-2025) (K Pcs)
Figure 88. Global Fibroblast Growth Factor Receptor 4 Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales Fibroblast Growth Factor Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 90. Europe Sales Fibroblast Growth Factor Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 91. Asia-Pacific Sales Fibroblast Growth Factor Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 92. South America Sales Fibroblast Growth Factor Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 93. Middle East & Africa Sales Fibroblast Growth Factor Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Amgen Inc、Genosco Inc、Blueprint Medicines Corp、ArQule Inc、Eli Lilly and Co、AstraZeneca Plc、Incyte Corp、Eisai Co Ltd、Bristol-Myers Squibb Co、H3 Biomedicine Inc、Novartis AG、Vichem Chemie Research Ltd、Ionis Pharmaceuticals Inc、Principia Biopharma Inc、NGM Biopharmaceuticals Inc、Johnson & Johnson、Tasly Pharmaceutical Group Co Ltd、Merrimack Pharmaceuticals Inc

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[線維芽細胞成長因子受容体4の世界市場2020:メーカー別、地域別、種類・用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆